Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Triumeq (abacavir/dolutegravir/lamivudine) and Biktarvy (bictegravir/emtricitabine/tenofovir) are both single-tablet regimens used to treat HIV, but they have some key differences. Triumeq requires a genetic test before starting treatment to check for a specific trait that could cause a serious allergic reaction, while Biktarvy does not. Triumeq is available in two forms: a tablet for adults and children over 55 lbs, and a dissolvable tablet for children between 13 lbs and 54 lbs. Biktarvy, on the other hand, is only available as a tablet for those weighing at least 30 lbs. Both medications can cause liver problems and need to be taken with caution if you have severe liver or kidney issues. Both medications are also brand-only and can be expensive.
Triumeq
Biktarvy
Triumeq
Biktarvy
Summary of Triumeq vs. Biktarvy
Summary for HIV ARV
Prescription only
Triumeq is a single-tablet regimen used to treat human immunodeficiency virus (HIV) infections. It contains 3 antiretrovirals (ARVs): abacavir, dolutegravir, and lamivudine. Triumeq is available as either a tablet or a dissolvable tablet for oral suspension (Triumeq PD), but the two are not the same. Before starting treatment, your provider will require you to get a genetic test to see if you're at risk for developing a serious allergic reaction to this medication.
Summary for HIV ARV Combo
Prescription only
Biktarvy is a combination antiretroviral that contains bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF). It's a complete antiretroviral therapy (ART) to treat human immunodeficiency virus (HIV) infections in adults and children who weigh at least 30 pounds. Biktarvy isn't used for HIV pre-exposure prophylaxis (PrEP), but it is a first-choice option for people starting HIV treatment. Typically, this medication is taken by mouth once daily. Biktarvy doesn't commonly cause weight gain, but it can cause other side effects, such as nausea, diarrhea, and headache.
Indications of Triumeq vs. Biktarvy
Indications for
•Treatment of HIV infection (in people who weigh at least 22 pounds)
Indications for
Treatment of HIV infection in adults and children weighing at least 30 lbs, and:
•Starting HIV treatment for the first time, or
•Have a HIV viral load of less than 50 copies/mL from a previous ART
Pros and Cons of Triumeq vs. Biktarvy
Pros and Const for HIV ARV
Pros
•Only taken once a day for complete HIV treatment
•Combines three medications into one pill for convenience
•Can be taken with or without food
•Available for adults and children at or over 22 lbs
Cons
•Dose can't be adjusted so it's not recommended for people with kidney or liver problems